Peak6 Investments LLC Neurocrine Biosciences Inc Transaction History

Peak6 Investments LLC

$43.5 Billion
Q3 2024

A detailed history of Peak6 Investments LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Peak6 Investments LLC holds 900 shares of NBIX stock, worth $123,021. This represents 0.0% of its overall portfolio holdings.

Number of Shares

900

Previous 900 -0.0%

Holding current value

$123,021

Previous $123,000 16.26%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$106.07 - $132.76 $138,421 - $173,251	1,305 Added 66.18%	3,277 $431,000
Q3 2023 Nov 13, 2023	BUY	$94.02 - $117.1 $185,407 - $230,921	1,972 New	1,972 $221,000
Q1 2022 May 13, 2022	SELL	$72.45 - $94.81 $367,321 - $480,686	-5,070 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$79.65 - $106.22 $222,303 - $296,460	-2,791 Reduced 35.5%	5,070 $432,000
Q3 2021 Nov 12, 2021	SELL	$86.18 - $99.03 $39,470 - $45,355	-458 Reduced 5.51%	7,861 $754,000
Q4 2020 Feb 12, 2021	SELL	$86.91 - $108.33 $322,523 - $402,012	-3,711 Reduced 30.85%	8,319 $797,000
Q3 2020 Nov 13, 2020	BUY	$96.16 - $135.15 $222,706 - $313,007	2,316 Added 23.84%	12,030 $1.16 Million
Q2 2020 Aug 14, 2020	SELL	$85.09 - $130.36 $539,215 - $826,091	-6,337 Reduced 39.48%	9,714 $1.19 Million
Q1 2020 May 14, 2020	BUY	$75.11 - $113.76 $1.01 Million - $1.53 Million	13,465 Added 520.69%	16,051 $1.39 Million
Q4 2019 Feb 13, 2020	SELL	$86.8 - $118.57 $1.8 Million - $2.46 Million	-20,787 Reduced 88.94%	2,586 $278,000
Q3 2019 Nov 08, 2019	SELL	$83.82 - $101.5 $428,236 - $518,563	-5,109 Reduced 17.94%	23,373 $2.11 Million
Q2 2019 Aug 14, 2019	SELL	$72.24 - $91.27 $1.7 Million - $2.15 Million	-23,576 Reduced 45.29%	28,482 $2.41 Million
Q1 2019 May 15, 2019	BUY	$69.31 - $91.53 $39,853 - $52,629	575 Added 1.12%	52,058 $4.59 Million
Q4 2018 Feb 13, 2019	BUY	$68.32 - $124.36 $3.52 Million - $6.4 Million	51,483 New	51,483 $3.68 Million

Others Institutions Holding NBIX

# of Institutions

627

Shares Held

94.2M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.

Account

Peak6 Investments LLC Neurocrine Biosciences Inc Transaction History